Search results
Results from the WOW.Com Content Network
Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure.
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
ADHD is the same condition in children and adults, but it can present differently in grown-ups, says Joshua M. Langberg, PhD, a licensed clinical psychologist in the Rutgers Graduate School of ...
People with undiagnosed ADHD may not be receiving the treatment they need to manage their symptoms and improve their quality of life. A new survey reports that 25% of adults in the United States ...
Psychosis risk increases 81% on high-dose amphetamine. For this study, researchers analyzed medical data from adults between the ages of 16 and 35 treated at Mass General Brigham between 2005 and ...
Intuniv - an extended release, non-stimulant alpha-2 adrenergic agonist used to treat attention deficit hyperactivity disorder. Available in instant-release under the brand-name Tenex . Invega ( paliperidone ) – atypical antipsychotic used to treat schizophrenia and schizoaffective disorder
The book had a sequel Contemporary Guide to Adult ADHD (2009), about adults with ADHD. It outlines clinical guidelines and recommended pharmacotherapies for the treatment of adult men and women. [citation needed] The author is a physician based in Rochester Hills, Michigan.